Evidence map›Paper›PMID 21655091›Full record

ArticlePLoS genetics2011

Genome-wide analysis reveals PADI4 cooperates with Elk-1 to activate c-Fos expression in breast cancer cells.

Xuesen Zhang, Matthew J Gamble, Sonja Stadler, Brian D Cherrington, Corey P Causey, Paul R Thompson, Mark S Roberson, W Lee Kraus, Scott A Coonrod

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Citrullination in tumor immunity and therapy.The Journal of clinical investigation · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Impact of increasedJournal of oral microbiology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. The monocyte cell surface is a unique site of autoantigen generation in rheumatoid arthritis.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Review
  12. Article
  13. An unbiased proteomic analysis of PAD4 in human monocytes: novel substrates, binding partners and subcellular localizations.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
  14. Neutrophil attachment via Mac-1 (Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
  15. Transcriptomic analysis of PADI4 target genes during multi-lineage differentiation of embryonic stem cells.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
  16. Citrullination and the protein code: crosstalk between post-translational modifications in cancer.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Xuesen ZhangBaker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Matthew J Gamble
Sonja Stadler
Brian D Cherrington
Corey P Causey
Paul R Thompson
Mark S Roberson
W Lee Kraus
Scott A Coonrod
Cornell University · USUniversity of South Carolina · USRockefeller University · USYeshiva University · US

Funding

Dose-Dependent Effects of Hormone on the Activity of Estrogen Receptor Enhancers and Target GenesR01DK058110 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI WILLIAM Lee KRAUS · 2000 to 2026
$10.4M
The Role of PARP-1 in Hormone-Regulated TranscriptionR01DK069710 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI KRAUS, WILLIAM LEE · 2004 to 2025
$7.9M
The Role of PARP-1 in Hormone-Regulated TranscriptionR56DK069710 · NIDDK · CORNELL UNIVERSITY · PI KRAUS, WILLIAM L · 2007 to 2007
$365k
NIDDK NIH HHS DK069710NIDDK NIH HHS DK58110NIDDK NIH HHS R01 DK058110NIDDK NIH HHS R01 DK069710NIDDK NIH HHS R56 DK069710
6 · The paper itself

Abstract

Peptidylarginine deiminase IV (PADI4) catalyzes the conversion of positively charged arginine and methylarginine residues to neutrally charged citrulline, and this activity has been linked to the repression of a limited number of target genes. To broaden our knowledge of the regulatory potential of PADI4, we utilized chromatin immunoprecipitation coupled with promoter tiling array (ChIP-chip) analysis to more comprehensively investigate the range of PADI4 target genes across the genome in MCF-7 breast cancer cells. Results showed that PADI4 is enriched in gene promoter regions near transcription start sites (TSSs); and, surprisingly, this pattern of binding is primarily associated with actively transcribed genes. Computational analysis found potential binding sites for Elk-1, a member of the ETS oncogene family, to be highly enriched around PADI4 binding sites; and coimmunoprecipitation analysis then confirmed that Elk-1 physically associates with PADI4. To better understand how PADI4 may facilitate gene transactivation, we then show that PADI4 interacts with Elk-1 at the c-Fos promoter and that, following Epidermal Growth Factor (EGF) stimulation, PADI4 catalytic activity facilitates Elk-1 phosphorylation, histone H4 acetylation, and c-Fos transcriptional activation. These results define a novel role for PADI4 as a transcription factor co-activator.

Indexed as

Genome, HumanBinding SitesBreast NeoplasmsCell Line, Tumorets-Domain Protein Elk-1FemaleGenome-Wide Association StudyHumansHydrolasesPhosphorylationPromoter Regions, GeneticProtein-Arginine DeiminasesProtein-Arginine Deiminase Type 4Proto-Oncogene Proteins c-fosTranscriptional Activationets-Domain Protein Elk-1HydrolasesPADI4 protein, humanProtein-Arginine DeiminasesProtein-Arginine Deiminase Type 4Proto-Oncogene Proteins c-fos

Identifiers

PMID21655091
PMCPMC3107201
OpenAlexW2067476102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.